全文获取类型
收费全文 | 4290篇 |
免费 | 298篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 151篇 |
妇产科学 | 68篇 |
基础医学 | 661篇 |
口腔科学 | 212篇 |
临床医学 | 382篇 |
内科学 | 881篇 |
皮肤病学 | 107篇 |
神经病学 | 478篇 |
特种医学 | 71篇 |
外科学 | 446篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 324篇 |
眼科学 | 39篇 |
药学 | 382篇 |
中国医学 | 2篇 |
肿瘤学 | 313篇 |
出版年
2021年 | 59篇 |
2020年 | 50篇 |
2019年 | 51篇 |
2018年 | 65篇 |
2017年 | 47篇 |
2016年 | 61篇 |
2015年 | 50篇 |
2014年 | 73篇 |
2013年 | 140篇 |
2012年 | 200篇 |
2011年 | 188篇 |
2010年 | 95篇 |
2009年 | 95篇 |
2008年 | 211篇 |
2007年 | 194篇 |
2006年 | 219篇 |
2005年 | 203篇 |
2004年 | 202篇 |
2003年 | 185篇 |
2002年 | 176篇 |
2001年 | 162篇 |
2000年 | 139篇 |
1999年 | 126篇 |
1998年 | 54篇 |
1997年 | 46篇 |
1996年 | 42篇 |
1995年 | 36篇 |
1994年 | 34篇 |
1993年 | 37篇 |
1992年 | 131篇 |
1991年 | 114篇 |
1990年 | 95篇 |
1989年 | 108篇 |
1988年 | 71篇 |
1987年 | 82篇 |
1986年 | 81篇 |
1985年 | 95篇 |
1984年 | 64篇 |
1983年 | 54篇 |
1982年 | 41篇 |
1981年 | 26篇 |
1980年 | 26篇 |
1979年 | 32篇 |
1978年 | 36篇 |
1977年 | 29篇 |
1975年 | 25篇 |
1974年 | 31篇 |
1973年 | 20篇 |
1972年 | 27篇 |
1971年 | 19篇 |
排序方式: 共有4605条查询结果,搜索用时 0 毫秒
71.
Tovi Lehmann Douglas H Graham Erica R Dahl Lilian M G Bahia-Oliveira S M Gennari J P Dubey 《Infection, genetics and evolution》2004,4(2):107-114
Previous studies of Toxoplasma gondii, based on samples dominated by clinical isolates, have concluded that its population structure is clonal, despite the sexual reproduction that occurs in cats. To determine whether this applies to non-clinical isolates, we compared patterns of linkage disequilibrium (LD) among seven loci in samples of T. gondii from Brazil and the US. LD was detected in both locations, but it was substantially lower in Brazil. The lower LD in Brazil can be explained by a higher rate of sexual reproduction between different genotypes (outcrossing) because of a higher rate of transmission. The extent of LD between pairs of physically unlinked loci varied significantly in each location. Moreover, the magnitude of LD between corresponding locus pairs in Brazil and the US was correlated, despite minimal gene exchange between the continents (mean FST = 0.19). The heterogeneity among locus pairs and the correlation in LD between physically unlinked locus pairs from different continents suggests that locus-specific factors, such as epistatic selection are involved in maintaining LD in T. gondii. Possibly, the unique life cycle of T. gondii with its unpredictable transmission among diverse host species and distinct ecological habitats requires specific combinations of alleles from multiple loci. The usefulness of typing isolates based on physically unlinked loci is questioned not only by the geographic variation in the reproductive population structure, but mainly by the low overall predictability of the genotype of one locus based on the genotype in another (unlinked) locus. This predictability ranged between 23 and 45%, but was close to nil for a considerable fraction of locus pairs. 相似文献
72.
Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease 总被引:2,自引:0,他引:2
NV Subhedar 《Acta paediatrica (Oslo, Norway : 1992)》2004,93(S444):29-32
Pulmonary hypertension with elevated pulmonary vascular resistance is a common cardiovascular complication associated with increased morbidity and mortality in preterm infants with chronic lung disease. Injury to the developing pulmonary circulation results in structural and functional abnormalities of the pulmonary vasculature. Animal studies have demonstrated that disruption of angiogenesis may contribute to the failure of normal alveolarisation in chronic lung disease. Levels of vascular endothelial growth factor in bronchoalveolar lavage fluid are lower in infants with chronic lung disease compared to preterm controls. Supplemental oxygen is commonly used to prevent and treat pulmonary hypertension, although optimal arterial oxygen saturation levels remain uncertain. Other vasodilators such as inhaled nitric oxide appear promising, but as yet have not been evaluated in the form of randomised controlled trials. Further studies are required to investigate the long-term effectiveness of pulmonary vasodilator therapy. 相似文献
73.
Ludvig Paul Muren Asa Karlsdottir Yngve Kvinnsland Tore Wentzel-Larsen Olav Dahl 《Radiotherapy and oncology》2005,75(3):293-302
BACKGROUND AND PURPOSE: To study the impact of the new ICRU 62 'Planning organ at Risk Volume' (PRV) concept on the relationship between rectum dose-volume histogram (DVH) data and toxicity. PATIENTS AND METHODS: The acute gastro-intestinal (GI) RTOG toxicity in 127 prostate cancer patients prescribed a total dose of 70 Gy with conformal irradiation to either the prostate, the prostate and seminal vesicles or the whole pelvis (initial 50 Gy only) were analysed. DVHs were derived for the rectum only and for rectum extended with six PRV margin sets (narrow/intermediate/wide; anterior/anterior and posterior). The data was analysed using permutation tests, logistic regression and effective uniform dose (EUD) calculations. RESULTS: Acute Grade 2 GI toxicity was seen in 22 of 127 cases (17%). Permutation tests showed that the difference between DVHs for patients with and without Grade 2 effects was significant, both for rectum only and rectum PRVs (P-value range: 0.02-0.04), with generally lower P-values for the PRVs. In the logistic regression, the fractional DVH variables (i.e. volumes) were significantly related to toxicity, with approximately 2-3 times as many significant dose levels for the PRVs as for rectum only. E.g. with wide anterior and posterior margins (16 and 11 mm, respectively) the relation was significant at 26 different dose levels (6-7, 13-14, 35-43, 60-71 and 73 Gy), compared to nine levels (38-40, 43-44 and 71-74 Gy) for rectum only. EUDs were significantly different for patients with and without Grade 2 effects both for rectum only and the PRVs (95% confidence interval for EUD increase with Grade 2 effects: 0.1-3.1 Gy). CONCLUSIONS: All statistical methods applied indicated a small, but definite difference in DVH parameters between patients with versus those without Grade 2 effects. The difference was most pronounced when margins of 16 mm anterior and 11 mm posterior were applied. 相似文献
74.
Poll LW Koch JA vom Dahl S Sarbia M Niederau C Häussinger D Mödder U 《Skeletal radiology》2000,29(1):15-21
Objective. To investigate the frequency and morphology of extraosseous extension in patients with Gaucher disease type I.
Design and patients. MRI examinations of the lower extremities were analyzed in 70 patients with Gaucher disease type I. Additionally, the thoracic
spine and the midface were investigated on MRI in two patients.
Results. Four cases are presented in which patients with Gaucher disease type I and severe skeletal involvement developed destruction
or protrusion of the cortex with extraosseous extension into soft tissues. In one patient, Gaucher cell deposits destroyed
the cortex of the mandible and extended into the masseter muscle. In the second patient, multiple paravertebral masses with
localized destruction of the cortex were apparent in the thoracic spine. In the third and fourth patient, cortical destruction
with extraosseous tissue extending into soft tissues was seen in the lower limbs.
Conclusions. Extraosseous extension is a rare manifestation of Gaucher bone disease. While an increased risk of cancer, especially hematopoietic
in origin, is known in patients with Gaucher disease, these extraosseous benign manifestations that may mimic malignant processes
should be considered in the differential diagnosis of extraosseous extension into soft tissues. A narrow neck of tissue was
apparent in all cases connecting bone and extraosseous extensions.
Received: 19 July 1999 Revision requested: 8 September 1999 Revision received: 7 October 1999 Accepted: 14 October 1999 相似文献
75.
J G Omichinski G Brunborg E J S?derlund J E Dahl J A Bausano J A Holme S D Nelson E Dybing 《Toxicology and applied pharmacology》1987,91(3):358-370
Selectively deuterated and methylated analogs of the nematocide 1,2-dibromo-3-chloropropane (DBCP) were compared to DBCP in causing acute renal damage in rats. All of the six deuterated analogs tested at 340 mumol/kg, including the perdeutero compound, failed to significantly alter the kidney necrosis observed at 48 hr compared to DBCP. Furthermore, when the perdeutero analog was administered at several doses (42.5, 85, 170, and 340 mumol/kg), it caused kidney damage that was not significantly different than that caused by an equivalent molar dose of nondeuterated DBCP. Of the five methylated analogs tested at 170 and 340 mumol/kg, only C3-methyl-DBCP and 1,2-dibromo-4-chlorobutane caused nephrotoxicity. The C2-methyl-, C1-dimethyl-, and C2-methyl-DBCP analogs failed to cause renal necrosis determined 48 hr after dosing. In distribution studies DBCP, perdeutero-DBCP, and all the methylated analogs were found to concentrate in the kidney approximately 25 times relative to plasma 1 hr after administration. DBCP at doses of 4.3 mumol/kg and higher caused DNA damage in the kidney as early as 10 min after administration, as measured by alkaline elution of DNA from isolated kidney nuclear preparations. Perdeuteration did not decrease the DNA damaging effect of DBCP. The ability of the methylated DBCP analogs to induce renal DNA damage correlated with their necrogenic potential. Experiments using pretreatments that are known to decrease the nephrotoxicity caused by glutathione and cysteine conjugates of several halogenated alkenes were conducted to examine the effect of these pretreatments on DBCP-induced nephrotoxicity. Probenecid, L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125) and aminooxyacetic acid did not significantly alter renal necrosis or DNA damage induced by DBCP. Based on the absence of any significant isotope effects with the predeutero-DBCP analog, it appears that breaking of a carbon-hydrogen bond is not the rate-limiting step in DBCP-induced nephrotoxicity. Studies with the methylated DBCP analogs indicate that a vicinal dibromo ethyl group must minimally be present for nephrotoxic potential. Furthermore, it seems unlikely that metabolism by renal cysteine conjugate beta-lyase is rate-limiting for DBCP nephrotoxicity. 相似文献
76.
The fate of isoprene inhaled by rats: comparison to butadiene 总被引:1,自引:0,他引:1
A R Dahl L S Birnbaum J A Bond P G Gervasi R F Henderson 《Toxicology and applied pharmacology》1987,89(2):237-248
Isoprene (2-methyl-1,3-butadiene), a volatile monomer occurring in the natural environment and used in the manufacture of elastomers, is a close chemical relative of the animal carcinogen 1,3-butadiene. To obtain toxicokinetic data for inhaled isoprene, male F344 rats were exposed in groups of 30 to 14C-labeled isoprene vapor at four concentrations from 8 to 8200 ppm. The percentage of the inhaled isoprene that was metabolized decreased with increasing exposure concentration. The percentage of the total metabolites (that is, non-isoprene-retained 14C) excreted in urine and feces or expired was determined as a function of vapor concentration. About 75% of the total metabolites was excreted in urine. This was independent of inhaled isoprene concentration. After exposure to 8200 ppm, a larger percentage of the metabolites was excreted in feces than after exposure to lower concentrations. Using vacuum line techniques, blood metabolite concentrations were determined as functions of both vapor concentration and exposure duration. At one exposure concentration (1480 ppm) metabolites were measured in the nose, lungs, liver, kidney, and fat, as well as in blood. A mutagenic metabolite, isoprene diepoxide, was tentatively identified in all tissues examined. Between 0.0018 and 0.031% of the inhaled 14C label was tentatively identified as this metabolite in blood. The relative amount of the metabolites present in blood was highest for low concentrations of inhaled isoprene and for shorter exposure durations. Body fat appeared to be a reservoir for both isoprene metabolites and isoprene itself. The appearance of metabolites in the respiratory tract after short exposure durations together with low blood concentrations of isoprene indicated that substantial metabolism of inhaled isoprene in the respiratory tract may occur. 相似文献
77.
Distribution of single wall carbon nanotubes in the Xenopus laevis embryo after microinjection
下载免费PDF全文
![点击此处可从《Journal of applied toxicology : JAT》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kris Noel Dahl Lance A. Davidson Mohammad F. Islam 《Journal of applied toxicology : JAT》2016,36(4):568-578
Single wall carbon nanotubes (SWCNTs) are advanced materials with the potential for a myriad of diverse applications, including biological technologies and large‐scale usage with the potential for environmental impacts. SWCNTs have been exposed to developing organisms to determine their effects on embryogenesis, and results have been inconsistent arising, in part, from differing material quality, dispersion status, material size, impurity from catalysts and stability. For this study, we utilized highly purified SWCNT samples with short, uniform lengths (145 ± 17 nm) well dispersed in solution. To test high exposure doses, we microinjected > 500 µg ml–1 SWCNT concentrations into the well‐established embryogenesis model, Xenopus laevis, and determined embryo compatibility and subcellular localization during development. SWCNTs localized within cellular progeny of the microinjected cells, but were heterogeneously distributed throughout the target‐injected tissue. Co‐registering unique Raman spectral intensity of SWCNTs with images of fluorescently labeled subcellular compartments demonstrated that even at regions of highest SWCNT concentration, there were no gross alterations to subcellular microstructures, including filamentous actin, endoplasmic reticulum and vesicles. Furthermore, SWCNTs did not aggregate and localized to the perinuclear subcellular region. Combined, these results suggest that purified and dispersed SWCNTs are not toxic to X. laevis animal cap ectoderm and may be suitable candidate materials for biological applications. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
78.
A cerebral glioma model for experimental therapy andin vivo invasion studies in syngeneic BD IX rats
Olav Mella Rolf Bjerkvig Baard-Christian Schem Olav Dahl Ole Didrik Laerum 《Journal of neuro-oncology》1990,9(2):93-104
Anin vivo glioma model was developed in syngeneic BD IX rats. The BT4An tumor was derived from serialin vivo passages of the BT4A tumor, originally induced from transformed fetal rat brain cells after transplacental exposure to ethylnitrosourea. The
cell line was characterized for the presence of neuroglial differentiation markers, chromosome content and cell cycle distribution
as determined by flowcytometry. A standardized method for i.c. tumor induction was developed, and the tumors were investigated
by light and electron microscopy and for evidence of blood-brain barrier disruption. Tumor cell ability for phagocytosis was
studied, as this property may be important for the invasion pattern of the tumors.
We conclude that the model seems suitable for bothin vivo therapy and invasion studies. The tumor had 100% tumor take, yielded a predictable symptom-free life span after inoculation,
had a characteristic histological picture of an aggressive glioma, and the blood-brain barrier within the tumor was in part
disrupted. Compared to the parent cell line, there was loss of neuroglial differentiation markers, the chromosomal distribution
was changed, and the ability for phagocytosis was practically lost. 相似文献
79.
80.